Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pao

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
Journal of Medicinal Chemistry|February 9, 2016
DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase InhibitorsPhilip A Harris, Bryan W King, Deepak Bandyopadhyay, et al.
Journal of Medicinal Chemistry|February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory DiseasesPhilip A Harris, Scott B Berger, Jae U Jeong, et al.
Science (New York, N.Y.)|November 16, 2016
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacteriumJosephine M Bryant, Dorothy M Grogono, Daniela Rodriguez-Rincon, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
Journal of Medicinal Chemistry|February 9, 2016
DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase InhibitorsPhilip A Harris, Bryan W King, Deepak Bandyopadhyay, et al.
Journal of Medicinal Chemistry|February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory DiseasesPhilip A Harris, Scott B Berger, Jae U Jeong, et al.
Science (New York, N.Y.)|November 16, 2016
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacteriumJosephine M Bryant, Dorothy M Grogono, Daniela Rodriguez-Rincon, et al.
Pageof 5